Latest Breaking News On - Can fite biopharma - Page 1 : comparemela.com

Can-Fite BioPharma (NYSE:CANF) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research note released on Friday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $18.00 price objective on shares of Can-Fite BioPharma in a research report on Thursday, May 9th. […]

Can-Fite to Participate in Partnering Meetings at Bio International Convention 2024

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announces that its VP of Business.

Can-Fite BioPharma (NYSE:CANF) Coverage Initiated by Analysts at StockNews.com

Analysts' New Coverage for May 24th (AEZS, AIRG, AWX, AZUL, BCLI, BLPH, BWMN, BZ, CALA, CAMP)

Join Can-Fite's Exclusive Live Investor Webinar and Q&A Session on June 6

Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, is pleased to invite investors to a.